Last Updated 24 January 2022.
9 Vaccines Approved for Use in India
-
Biological E Limited
Corbevax- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 1 country
7 trials in 1 country
Approval Source: bbc.com
-
Serum Institute of India
COVOVAX (Novavax formulation)- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 3 countries
2 trials in 1 country
Approval Source: timesofindia.indiatimes.com
-
Zydus Cadila
ZyCoV-D- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 1 country
5 trials in 1 country
Approval Source: reuters.com
-
Moderna
Spikevax- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 85 countries
45 trials in 19 countries
Approval Source: france24.com
-
Gamaleya
Sputnik V- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 74 countries
22 trials in 7 countries
Approval Source: pib.gov.in
-
Janssen (Johnson & Johnson)
Ad26.COV2.S- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 106 countries
18 trials in 18 countries
Approval Source: reuters.com
-
Oxford/AstraZeneca
Vaxzevria- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 137 countries
56 trials in 30 countries
Approval Source: nytimes.com
-
Serum Institute of India
Covishield (Oxford/AstraZeneca formulation)- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 47 countries
2 trials in 1 country
Approval Source: cdsco.gov.in
-
Bharat Biotech
Covaxin- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 13 countries
7 trials in 1 country
Approval Source: bbc.com
14 Vaccines in Clinical Trials in India
-
Biological E Limited
Corbevax- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 1 country
7 trials in 1 country
-
Novavax
Nuvaxovid- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 32 countries
11 trials in 7 countries
-
Serum Institute of India
COVOVAX (Novavax formulation)- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 3 countries
2 trials in 1 country
-
University Medical Center Groningen
AKS-452- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
4 trials in 2 countries
-
Zydus Cadila
ZyCoV-D- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 1 country
5 trials in 1 country
-
Gamaleya
Sputnik V- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 74 countries
22 trials in 7 countries
-
Oxford/AstraZeneca
Vaxzevria- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 137 countries
56 trials in 30 countries
-
Serum Institute of India
Covishield (Oxford/AstraZeneca formulation)- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 47 countries
2 trials in 1 country
-
Bharat Biotech
Covaxin- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 13 countries
7 trials in 1 country
-
Biological E Limited
BECOV2B- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
Biological E Limited
BECOV2C- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
Biological E Limited
BECOV2D- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
Gennova Biopharmaceuticals Limited
HGCO19- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
Bharat Biotech
BBV154- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country